|
![]() |
|||
|
||||
OverviewFull Product DetailsAuthor: David J. Kerr (University of Birmingham, Birmingham, England, UK) , Alexander Levitzki , Paul Workman , Garth PowisPublisher: Taylor & Francis Inc Imprint: CRC Press Inc Weight: 0.285kg ISBN: 9780849349058ISBN 10: 0849349052 Pages: 236 Publication Date: 27 June 1994 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Out of Print Availability: Out of stock ![]() Table of ContentsThe Potential for Molecular Oncology to Define New Drug Targets (P. Workman). An Overview of the Regulation of Phospholipase-Linked Cell Signaling (M.J.O. Wakelam). Growth Factor Receptors as Targets (F.J. Lofts and W.J. Gullick). Protein Tyrosine Kinase Inhibitors (A. Levitzkie). Inhibitors of myo-Inositol Signaling (G. Powis and A. Kozikowski). The Properties of ras p21 and Its Potential Value as a Therapeutic Target (R.J.A. Grand). Protein Kinase C (A. Basu and J.S. Lazo). Apoptosis as a Target for Cancer Chemotherapy (A. Eastman and M.A. Barry). DNA Sequences as Targets for New Anticancer Agents (S. Neidle and D.E. Thurston). P-Glycoprotein, a Transporter with Allosterically Coupled Drug--Acceptor Sites as a Target for Rational Drug-Design (D.R. Ferry and D.J. Kerr). The Clinical Evaluation of Novel Chemotherapeutic Agents (C.J. Poole and D.J. Kerr). Index.ReviewsAuthor InformationKerr\, David J.; Workman\, Paul Tab Content 6Author Website:Countries AvailableAll regions |